Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution

Int J Cardiol. 2016 Oct 15:221:58-9. doi: 10.1016/j.ijcard.2016.06.304. Epub 2016 Jun 29.
No abstract available

Keywords: Bleeding; LVAD; Thrombosis; Ticagrelor.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenosine / administration & dosage
  • Adenosine / adverse effects
  • Adenosine / analogs & derivatives*
  • Aged
  • Aspirin* / administration & dosage
  • Aspirin* / adverse effects
  • Blood Coagulation / drug effects
  • Cardiomyopathies / surgery*
  • Clopidogrel
  • Drug Substitution / methods
  • Drug Therapy, Combination / methods
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Male
  • Medication Therapy Management
  • Postoperative Complications* / diagnosis
  • Postoperative Complications* / physiopathology
  • Risk Adjustment
  • Thrombosis* / diagnosis
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology
  • Thrombosis* / physiopathology
  • Ticagrelor
  • Ticlopidine / administration & dosage
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Clopidogrel
  • Ticagrelor
  • Adenosine
  • Ticlopidine
  • Aspirin